Anavex Life Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Anavex Life Stock Summary

Anavex Life competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, and Enliven Therapeutics. Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system diseases. The company was incorporated in 2004 and is headquartered in New York, New York. Anavex Lf operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.

Anavex Life Key Financial Ratios

Anavex Life Key Balance Sheet Accounts

Anavex Life Key Income Statement Accounts

Anavex Life Key Cash Accounts

Anavex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Anavex Life's current stock value. Our valuation model uses many indicators to compare Anavex Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anavex Life competition to find correlations between indicators driving Anavex Life's intrinsic value. More Info.Anavex Life Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At this time, Anavex Life's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Anavex Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Anavex Life Sciences Systematic Risk

Today, most investors in Anavex Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Anavex Life's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Anavex Life growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Anavex Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Anavex Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Anavex Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Anavex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Anavex Life's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.